PACCAR Inc (FRA:PAE)

Inozyme Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	43,878	52,678	46,211	32,205	26,943	24,436
Market Cap Growth	-15.62%	14.00%	43.49%	19.53%	10.26%	0.23%
Enterprise Value	50,630	58,918	51,247	37,518	32,449	29,375
Last Close Price	84.25	98.68	84.26	55.92	45.03	38.92
PE Ratio	16.77	13.10	11.10	11.43	16.43	22.97
PS Ratio	1.66	1.62	1.45	1.19	1.30	1.60
PB Ratio	2.72	3.12	3.22	2.61	2.64	2.88
P/TBV Ratio	2.72	3.12	3.22	2.61	2.64	2.88
P/FCF Ratio	-	18.84	17.45	21.03	55.32	22.16
P/OCF Ratio	-	11.75	12.19	11.37	14.01	10.01
EV/Sales Ratio	1.88	1.81	1.61	1.39	1.57	1.92
EV/EBITDA Ratio	13.49	11.37	8.74	8.78	11.22	13.45
EV/EBIT Ratio	14.81	12.22	9.37	10.61	15.46	22.15
EV/FCF Ratio	20.65	21.07	19.35	24.50	66.63	26.64
Debt / Equity Ratio	0.93	0.91	0.91	0.88	0.91	1.06
Debt / EBITDA Ratio	4.11	2.97	2.22	2.53	3.18	4.09
Debt / FCF Ratio	6.14	5.53	4.93	7.09	19.00	8.16
Asset Turnover	0.73	0.80	0.95	0.92	0.81	0.66
Inventory Turnover	9.36	10.55	11.26	11.16	11.94	12.69
Quick Ratio	1.40	1.82	2.04	2.10	2.22	2.35
Current Ratio	1.73	2.04	2.30	2.40	2.57	2.65
Return on Equity (ROE)	16.77%	24.93%	31.68%	24.32%	16.97%	12.95%
Return on Assets (ROA)	5.79%	7.41%	10.19%	7.52%	5.16%	3.58%
Return on Capital (ROIC)	7.18%	9.78%	13.71%	10.08%	6.86%	4.78%
Return on Capital Employed (ROCE)	10.80%	19.00%	22.60%	16.60%	11.20%	7.80%
Earnings Yield	5.96%	7.63%	9.01%	8.75%	6.09%	4.35%
FCF Yield	5.59%	5.31%	5.73%	4.75%	1.81%	4.51%
Dividend Yield	4.72%	1.15%	1.12%	1.57%	1.76%	1.79%
Payout Ratio	72.73%	54.99%	33.01%	0.16%	37.95%	95.28%
Buyback Yield / Dilution	-0.15%	-0.30%	-0.31%	-0.13%	-0.29%	0.01%
Total Shareholder Return	4.57%	0.84%	0.81%	1.44%	1.47%	1.80%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.